ArticleAnnals of the American Thoracic Society2026

Elexacaftor-tezacaftor-ivacaftor for individuals with residual CFTR activity: an open-label, nonrandomized clinical trial.

Rachel W Linnemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.